Quebec’s Repare Therapeutics raises $68M in Series A funding

Quebec-based Repare Therapeutics has raised $68M in Series A funding in a round led by MPM Capital and Versant Ventures. The round also saw participation from BDC Healthcare, Celgene and the Fonds de solidarité FTQ. Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.



Fundingportal leverages innovation to help businesses, nonprofits, and municipalities like yours to get grants and funding.

Read Previous

Fredericton’s Envenio raises $1.3M in venture funding

Read Next

Toronto’s Hubdoc raises $4.9M in seed funding

coding4pro honey homes